Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial

Abstract

Purpose

The objective of this prospective randomized controlled trial was to assess the efficacy and safety of simultaneous application of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty (TKA).

Methods

Seventy-two primary osteoarthritis patients undergoing unilateral TKA using fondaparinux as a basic thromboprophylaxis were randomized to receive either placebo (36 patients) or tranexamic acid (36 patients). Prophylaxis against venous thromboembolism in all patients was administered with subcutaneous doses of 2.5 mg fondaparinux for 5 days post-operatively. Post-operative retransfusion volume, allogenic transfusion volumes and drain amount were recorded for each patient. Level of haemoglobin, prothrombin time, activated partial thromboplastin time and D-dimer were also assessed. Doppler ultrasonography was performed preoperatively and 7 days after surgery.

Results

The rate of transfusion was lower in the tranexamic acid group than in the placebo group (p = 0.007). The drained blood volume during the initial 24 h and until drain removal was smaller in the tranexamic acid group than in the placebo group (p < 0.001). However, the haematologic laboratory results did not show any significant differences between the two groups. The prevalence of deep-vein thrombosis (DVT) was 4 (11.1 %) in the placebo group and 3 (8.3 %) in the tranexamic acid group (p = n.s.). There was no proximal DVT and no symptomatic pulmonary embolism in either group.

Conclusion

The use of tranexamic acid could reduce acute blood loss significantly without any adverse effect resulted from drug interaction with concomitant use of indirect factor Xa inhibitor following TKA. Therefore, simple combination of these drugs can be recommended to reduce post-operative blood loss as well as to reduce DVT following TKA.

Level of evidence

Therapeutic, Level I.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78:434–440

  2. 2.

    Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358:9–15

  3. 3.

    Ekback G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckstrom J, Carlsson O, Schott U (2000) Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 91:1124–1130

  4. 4.

    Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92:775–780

  5. 5.

    Eriksson O, Kjellman H, Pilbrant A, Schannong M (1974) Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 7:375–380

  6. 6.

    Guijarro R, Montes J, San Roman C, Arcelus JI, Barillari G, Granero X, Monreal M (2011) Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database. Thromb Haemost 105:610–615

  7. 7.

    Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemela HM, Mantyla SK, Kuisma RP, Ylinen JE (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839–844

  8. 8.

    Howes JP, Sharma V, Cohen AT (1996) Tranexamic acid reduces blood loss after knee arthroplasty. J Bone Joint Surg Br 78:995–996

  9. 9.

    Hynes M, Calder P, Scott G (2003) The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 10:375–377

  10. 10.

    Hynes MC, Calder P, Rosenfeld P, Scott G (2005) The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl 87:99–101

  11. 11.

    Jansen AJ, Andreica S, Claeys M, D’Haese J, Camu F, Jochmans K (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83:596–601

  12. 12.

    Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123:687–696

  13. 13.

    Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest 133:454S–545S

  14. 14.

    Kim KI, Cho KY, Jin W, Khurana SS, Bae DK (2011) Recent Korean perspective of deep vein thrombosis after total knee arthroplasty. J Arthroplast 26:1112–1116

  15. 15.

    Kim YH, Kim JS (2002) Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br 84:566–570

  16. 16.

    Lachiewicz PF (2011) Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty. Instr Course Lect 60:301–307

  17. 17.

    Lemaire R (2008) Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 90:1128–1136

  18. 18.

    Lieberman JR, Hsu WK (2005) Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 87:2097–2112

  19. 19.

    Lin PC, Hsu CH, Chen WS, Wang JW (2011) Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res 469:1995–2002

  20. 20.

    Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F (2008) Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 95:39–44

  21. 21.

    MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT (2011) Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplast 26:24–28

  22. 22.

    Oishi CS, Grady-Benson JC, Otis SM, Colwell CW Jr, Walker RH (1994) The clinical course of distal deep venous thrombosis after total hip and total knee arthroplasty, as determined with duplex ultrasonography. J Bone Joint Surg Am 76:1658–1663

  23. 23.

    Onodera T, Majima T, Sawaguchi N, Kasahara Y, Ishigaki T, Minami A (2012) Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplast 27:105–108

  24. 24.

    Orpen NM, Little C, Walker G, Crawfurd EJ (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13:106–110

  25. 25.

    Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 91:776–783

  26. 26.

    Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A:216–220

  27. 27.

    Seo JG, Moon YW, Park SH, Kim SM, Ko KR (2012) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc doi:10.1007/s00167-012-2079-2

  28. 28.

    Stulberg BN, Insall JN, Williams GW, Ghelman B (1984) Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 66:194–201

  29. 29.

    Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93:39–46

  30. 30.

    Sundstrom A, Seaman H, Kieler H, Alfredsson L (2009) The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the general practice research database. BJOG 116:91–97

  31. 31.

    Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83:702–705

  32. 32.

    Toftdahl K, Nikolajsen L, Haraldsted V, Madsen F, Tonnesen EK, Soballe K (2007) Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial. Acta Orthop 78:172–179

  33. 33.

    Trca S, Krska Z, Sedlar M, Kudrnova Z, Dohnalova A (2007) Comparison of various types of pharmacological prevention of lower extremities deep vein thrombosis in patients with proximal femoral fractures. Rozhl Chir 86:241–248

  34. 34.

    Walzman M, Bonnar J (1982) Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. Arch Toxicol Suppl 5:214–220

  35. 35.

    Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM (2000) Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc 99:848–853

  36. 36.

    Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Yu PC (2004) Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin. J Bone Joint Surg Am 86-A:136–140

  37. 37.

    Watanabe H, Sekiya H, Kariya Y, Hoshino Y, Sugimoto H, Hayasaka S (2011) The incidence of venous thromboembolism before and after total knee arthroplasty using 16-row multidetector computed tomography. J Arthroplast 26:1488–1493

  38. 38.

    White RH, Goulet JA, Bray TJ, Daschbach MM, McGahan JP, Hartling RP (1990) Deep-vein thrombosis after fracture of the pelvis: assessment with serial duplex-ultrasound screening. J Bone Joint Surg Am 72:495–500

  39. 39.

    Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92:2503–2513

  40. 40.

    Xu ZQ, Li Y, Liao RZ, Fang YZ, Liu ZH (2010) Clinical analysis of preoperative deep venous thrombosis (DVT) complicated lower extremity close fractures. Zhongguo Gu Shang 23:52–54

  41. 41.

    Zhang H, Chen J, Chen F, Que W (2012) The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 20:1742–1752

  42. 42.

    Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B (2004) The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99:1679–1683

Download references

Acknowledgments

This study did not receive any external funding.

Author information

Correspondence to Kang-Il Kim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, S.H., Cho, K., Khurana, S. et al. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 21, 2611–2617 (2013). https://doi.org/10.1007/s00167-012-2213-1

Download citation

Keywords

  • Total knee arthroplasty
  • Fondaparinux
  • Tranexamic acid
  • Deep-vein thrombosis